Health Condition 1: C20- Malignant neoplasm of rectum
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: Nil: Nil
Intervention5: Nil: Nil
Sponsors
Jawaharlal Nehru Medical College, Wardha
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of all age group irrespective of sex will be included. 2. Patients referred with clinical suspicion of rectal carcinoma as part of their clinical evaluation. 3. Patients who have given informed consent for MRI evaluation and inclusion in the study.
Exclusion criteria
Exclusion criteria: 1. Patient with profuse per rectal bleeding including hemorrhoids. 2. Patients with contraindications to MRI (e.g., pacemakers, cochlear implants, or metallic foreign bodies, claustrophobia) 3. Patients who do not give consent/refusing investigations. 4. Pregnant patients unwilling to undergo MRI.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate characteristics of rectal lesion on MRI. 2.To compare the effectiveness of T2-weighted and diffusion-weighted MRI in staging the primary tumour and regional lymph nodes. 3.To assess the accuracy of MRI in predicting mesorectal fascia involvement and resection margin status in rectal cancer. 4.To correlate MRI findings with the histopathological diagnosis of rectal lesions. Timepoint: Outcomes will be assessed at baseline(pre treatment), 4 weeks, 8 weeks, and at final follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: | — |
Countries
India
Contacts
Public ContactDr Shivali Kashikar
DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH
Outcome results
None listed